• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的嗅觉丧失。

Olfactory loss in Parkinson's disease.

机构信息

Department of Otorhinolaryngology and Department of Neurology, Medical School, Dresden University of Technology, Fetscherstraße 74, 01307 Dresden, Germany.

出版信息

Parkinsons Dis. 2011;2011:450939. doi: 10.4061/2011/450939. Epub 2011 Apr 21.

DOI:10.4061/2011/450939
PMID:21687752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3109349/
Abstract

Impairment of olfaction is a characteristic and early feature of Parkinson's disease. Recent data indicate that >95% of patients with Parkinson's disease present with significant olfactory loss. Deficits in the sense of smell may precede clinical motor symptoms by years and can be used to assess the risk for developing Parkinson's disease in otherwise asymptomatic individuals. This paper summarizes the available information about olfactory function in Parkinson's disease, indicating the advantageous use of olfactory probes in early and differential diagnosis.

摘要

嗅觉障碍是帕金森病的一个特征性和早期特征。最近的数据表明,超过 95%的帕金森病患者存在明显的嗅觉丧失。嗅觉缺陷可能在数年之前就先于临床运动症状出现,并可用于评估无症状个体发生帕金森病的风险。本文总结了有关帕金森病嗅觉功能的现有信息,表明嗅觉探针在早期和鉴别诊断中的有利应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/7da37ed07a30/PD2011-450939.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/f0264e7f5061/PD2011-450939.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/f07ae9deb906/PD2011-450939.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/7da37ed07a30/PD2011-450939.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/f0264e7f5061/PD2011-450939.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/f07ae9deb906/PD2011-450939.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/3109349/7da37ed07a30/PD2011-450939.003.jpg

相似文献

1
Olfactory loss in Parkinson's disease.帕金森病中的嗅觉丧失。
Parkinsons Dis. 2011;2011:450939. doi: 10.4061/2011/450939. Epub 2011 Apr 21.
2
A clinical approach towards smell loss in Parkinson's disease.帕金森病嗅觉丧失的临床处理方法。
J Parkinsons Dis. 2014;4(2):189-95. doi: 10.3233/JPD-130278.
3
Olfactory dysfunction as a diagnostic marker for Parkinson's disease.嗅觉障碍作为帕金森病的诊断标志物。
Expert Rev Neurother. 2009 Dec;9(12):1773-9. doi: 10.1586/ern.09.115.
4
Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline.帕金森病中的嗅觉障碍是中枢神经系统衰退的结果。
J Neurol. 2017 Jun;264(6):1236-1246. doi: 10.1007/s00415-017-8521-0. Epub 2017 May 26.
5
Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.早期帕金森病的弥散张量成像和嗅觉识别测试。
J Neurol. 2011 Jul;258(7):1254-60. doi: 10.1007/s00415-011-5915-2. Epub 2011 Feb 3.
6
University of Pennsylvania Smell Identification Test Abnormalities in Parkinson's Disease.宾夕法尼亚大学嗅觉识别测试在帕金森病中的异常情况。
J Assoc Physicians India. 2016 Apr;64(4):32-36.
7
Smell deficits in COVID-19 and possible links with Parkinson's disease.新冠病毒嗅味觉丧失与帕金森病的可能关联。
Int Rev Neurobiol. 2022;165:91-102. doi: 10.1016/bs.irn.2022.08.001. Epub 2022 Sep 6.
8
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.雷沙吉兰改善帕金森病α-突触核蛋白模型小鼠的嗅觉缺陷。
PLoS One. 2013;8(4):e60691. doi: 10.1371/journal.pone.0060691. Epub 2013 Apr 3.
9
Evaluation of Olfactory Function by Iranian Smell Diagnostic Test in Patients with Parkinson's disease in North of Iran.伊朗嗅觉诊断测试对伊朗北部帕金森病患者嗅觉功能的评估
Iran J Otorhinolaryngol. 2021 Sep;33(118):271-279. doi: 10.22038/ijorl.2021.50564.2688.
10
Olfaction in Parkinson's disease and related disorders.帕金森病及相关疾病的嗅觉障碍。
Neurobiol Dis. 2012 Jun;46(3):527-52. doi: 10.1016/j.nbd.2011.10.026. Epub 2011 Dec 20.

引用本文的文献

1
The Impact of Olfactory Loss on Quality of Life: A 2025 Review.嗅觉丧失对生活质量的影响:2025年综述
Chem Senses. 2025 Jul 25;50. doi: 10.1093/chemse/bjaf023.
2
Redefining Non-Motor Symptoms in Parkinson's Disease.重新定义帕金森病的非运动症状
J Pers Med. 2025 Apr 26;15(5):172. doi: 10.3390/jpm15050172.
3
Towards universal chemosensory testing: needs, barriers, and opportunities.迈向通用化学感应测试:需求、障碍与机遇。

本文引用的文献

1
Olfactory FMRI in patients with Parkinson's disease.帕金森病患者的嗅觉 fMRI 研究。
Front Integr Neurosci. 2010 Oct 28;4:125. doi: 10.3389/fnint.2010.00125. eCollection 2010.
2
A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease.基本嗅觉测试与多巴胺转运体扫描一样敏感:嗅觉、味觉和 DaTSCAN 在帕金森病诊断中的比较。
QJM. 2010 Dec;103(12):941-52. doi: 10.1093/qjmed/hcq142. Epub 2010 Aug 23.
3
Idiopathic phantosmia: outcome and clinical significance.
Chem Senses. 2025 Jan 22;50. doi: 10.1093/chemse/bjaf015.
4
Neural and vascular contributions to sensory impairments in a human alpha-synuclein transgenic mouse model of Parkinson's disease.在帕金森病的人α-突触核蛋白转基因小鼠模型中,神经和血管对感觉障碍的影响
J Cereb Blood Flow Metab. 2025 May 7:271678X251338952. doi: 10.1177/0271678X251338952.
5
The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease.突变型LRRK2对突变型GBA1相关帕金森病的修饰作用。
Hum Mol Genet. 2025 May 2. doi: 10.1093/hmg/ddaf062.
6
Combined MR Volumetry and T2* Relaxometry Reveals the Olfactory System as an Iron-Dependent Structure Affected by Radiation.联合磁共振容积测量和T2*弛豫测量揭示嗅觉系统是一个受辐射影响的铁依赖结构。
Neurol Int. 2025 Apr 8;17(4):53. doi: 10.3390/neurolint17040053.
7
Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.利用多个队列、机器学习和项目反应理论开发一种简化嗅觉测试以识别帕金森病。
NPJ Parkinsons Dis. 2025 Apr 23;11(1):85. doi: 10.1038/s41531-025-00904-5.
8
The AROMHA brain health test is a remote olfactory assessment to screen for cognitive impairment.AROMHA脑健康测试是一种用于筛查认知障碍的远程嗅觉评估。
Sci Rep. 2025 Mar 24;15(1):9290. doi: 10.1038/s41598-025-92826-8.
9
Chemosensory Impairments and Their Impact on Nutrition in Parkinson's Disease: A Narrative Literature Review.化学感觉障碍及其对帕金森病营养状况的影响:一篇叙述性文献综述
Nutrients. 2025 Feb 13;17(4):671. doi: 10.3390/nu17040671.
10
Visualizing the human olfactory projection and ancillary structures in a 3D reconstruction.三维重建中嗅神经投射和辅助结构的可视化。
Commun Biol. 2024 Nov 8;7(1):1467. doi: 10.1038/s42003-024-07017-4.
特发性嗅觉幻觉:结果与临床意义。
ORL J Otorhinolaryngol Relat Spec. 2010;72(5):252-5. doi: 10.1159/000317024. Epub 2010 Aug 12.
4
Parkinson's disease symptoms: the patient's perspective.帕金森病症状:患者的视角。
Mov Disord. 2010 Aug 15;25(11):1646-51. doi: 10.1002/mds.23135.
5
Parkinson's at risk syndrome: can Parkinson's disease be predicted?帕金森病高危综合征:帕金森病能否预测?
Mov Disord. 2010;25 Suppl 1:S89-93. doi: 10.1002/mds.22719.
6
A timeline for Parkinson's disease.帕金森病时间表。
Parkinsonism Relat Disord. 2010 Feb;16(2):79-84. doi: 10.1016/j.parkreldis.2009.08.007. Epub 2009 Oct 28.
7
Olfactory disturbance in Parkinson disease.
Arch Neurol. 2009 Jun;66(6):805; author reply 805-6. doi: 10.1001/archneurol.2009.87.
8
Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.嗅觉障碍在轻度路易体痴呆患者中比轻度阿尔茨海默病患者更为明显。
J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):667-70. doi: 10.1136/jnnp.2008.155895.
9
Parkinsonism: the hyposmia and phantosmia connection.帕金森症:嗅觉减退与嗅觉幻觉的关联
Arch Neurol. 2009 Apr;66(4):538-9; author reply 539. doi: 10.1001/archneurol.2009.38.
10
Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study.嗅觉减退和执行功能障碍作为未来帕金森病的预测指标:一项前瞻性研究。
Mov Disord. 2009 May 15;24(7):1060-5. doi: 10.1002/mds.22534.